From Health Canada:
Berlex Canada Inc., in collaboration with Health Canada, is informing healthcare professionals of new safety information regarding ZEVALIN. ZEVALIN, as part of the ZEVALIN treatment regimen, is a medication used for the treatment of patients with some types of non-Hodgkin's lymphoma that have received and are not responding to other treatments, including patients with non-Hodgkin's lymphoma that is not responsive to rituximab.
For the public...
For health professionals...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment